Disclaimer: The following content discusses our Trans-Arterial Micro-Perfusion (TAMP™) therapy platform, which is enabled by our FDA-cleared RenovoCath. RenovoCath is indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, and chemotherapeutic drug infusion. RenovoCath-enabled TAMP with gemcitabine for the treatment of locally advanced pancreatic cancer (LAPC) is being studied under an IND. This combination product candidate has not been approved by FDA for commercial use and its safety and effectiveness in treating LAPC has not been established. For RenovoCath’s Indications for Use and safety information, please visit IFU-10004-Rev.-H-Universal-IFU.pdf.
Released July 25, 2026
Hernando Salcedo was surprised when he noticed his stomach swelling in May 2025. The 83-year-old grandfather had always been healthy and active. He'd had some hip pain recently, but thought it was his age. The swelling came out of nowhere and didn't have a clear cause.